1. Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Maselli R. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. 2015:879783.
2. Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626-35.
3. de Groot J, ten Brinke A, Bel E. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res 2015; 1: 00024-2016. - July 01, 2016.
4. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–813.
5. Koćwin M, Jonakowski M, Przemęcka M, Zioło J, Panek M, Kuna P. The role of the TGF-SMAD signaling pathway in the etiopathogenesis of severe asthma. Adv Respir Med. 2016;84(5):290-301.
6. Heldin C, Aristidis Moustakas A. Signaling Receptors for TGF-β Family Members. Cold Spring Harb Perspect Biol. 2016;1;8(8).
7. Venge P. The eosinophil and airway remodelling in asthma. Clin Respir J 2010; 4(Suppl 1): 15-9.
8. Torrego A, Hew M, Oates T i wsp. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 2007; 62(4): 307-13.
9. Czarniakowska-Bołtuć M, Ziętkowski Z, Bodzenta-Łukaszyk A. Role of selected growth factors in asthma. Alergia Astma Immunologia 2012, 17 (4): 172-179.
10. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003 Oct 9;425(6958): 577-84.doi:10.1038/nature02006.
11. Panek M, Pietras T, Fabijan A, Zioło J, Wieteska Ł, Małachowska B, Fendler W, Szemraj J, Kuna P. Identification and association of the single nucleotide polymorphisms, C-509T, C+466T and T+869C, of the TGF-β1 gene in patients with asthma and their influence on the mRNA expression level of TGF-β1. Int J Mol Med. 2014 Oct;34(4): 975-86.doi: 10.3892/ijmm.2014.1894.
12. Panek M, Pietras T, Szemraj J, Fabijan A, Kuna P. Identification and association of TGFβ-1 expression in patients with asthma in a Polish population - Lodz metropolitan area study. Int J Biochem Mol Biol. 2013; 4:67–74.
13. Panek M, Pietras T, Fabijan A, Miłanowski M, Wieteska L, Górski P, Kuna P, Szemraj J. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp Ther Med. 2013; 5:572–580.
14. Mokrosiński J, Krajewska WM. TGFβ signalling accessory receptors. Postepy Biochem. 2008;54(3):264-73.
15. de Caestacker M (2004) The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 15: 1-11.
16. Massague J (1998) TGF-β signal transduction. Annu Rev Biochem 67:753-791.
17. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 7:1191-1204.
18. Hata A, Chen YG. TGF-beta Signaling from Receptors to Smads. Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a022061. doi: 10.1101/cshperspect.a022061.
19. Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY. New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018 Aug 25;292:76-83. doi: 10.1016/j.cbi.2018.07.008. Epub 2018 Jul 11.
20. Panek M, Jonakowski M, Zioło J, Wieteska Ł, Małachowska B, Pietras T, Szemraj J, Kuna P. A novel approach to understanding the role of polymorphic forms of the NR3C1 and TGF-β1 genes in the modulation of the expression of IL-5 and IL-15 mRNA in asthmatic inflammation. Mol Med Rep. 2016 Jun;13(6):4879-87.
21. Panek M, Pietras T, Fabijan A, Zioło J, Wieteska Ł, Małachowska B, Fendler W, Szemraj J, Kuna P. The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients. Inflammation. 2015 Aug;38(4):1479-92.
22. Panek M, Pietras T, Fabijan A, Miłanowski M, Wieteska L, Górski P, Kuna P, Szemraj J. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp Ther Med. 2013 Feb;5(2):572-580.
23. Panek M, Pietras T, Fabijan A, Zioło J, Wieteska L, Małachowska B, Fendler W, Szemraj J, Kuna P. Identification and association of the single nucleotide polymorphisms, C-509T, C+466T and T+869C, of the TGF-β1 gene in patients with asthma and their influence on the mRNA expression level of TGF-β1. Int J Mol Med. 2014 Oct;34(4):975-86.
24. Pietras T, Panek M, Tworek D, Oszajca K, Wujcik R, Górski P, Kuna P, Szemraj J. The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study. Mol Biol Rep. 2011 Aug;38(6):3953-8.
25. Pietras T, Panek M, Kuprys-Lipinska I, Oszajca K, Wujcik R, Kuna P, Gorski P, Szemraj J. Frequencies of Bcl I, E22E, and N363S of h-GR/NR3C1 restriction fragment length polymorphisms of glucocorticoid receptor gene in Polish adult population. Med Sci Monit. 2010 Oct;16(10):CR475-9.
26. Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. J Allergy Clin Immunol. 2005;115: S460–82.
27. Ellis, A.K., Soliman, M., Steacy, L. et al. The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. All Asth Clin Immun 11, 16 (2015). https://doi.org/10.1186/s13223-015-0082-0.
28. Augé J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, Cingi C, Durham S, Fokkens W, Gevaert P, Giotakis A, Hellings P, Herknerova M, Hox V, Klimek L, La Melia C, Mullol J, Muluk NB, Muraro A, Naito K, Pfaar O, Riechelmann H, Rondon C, Rudenko M, Samolinski B, Tasca I, Tomazic P, Vogt K, Wagenmann M, Yeryomenko G, Zhang L, Mösges R. EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018 Aug;73(8):1597-1608. doi: 10.1111/all.13416.
29. Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen, Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017 May 1;49(5):1601526. doi: 10.1183/13993003.01526-2016.
30. Panek M, Pietras T, Antczak A, Górski P, Kuna P, Szemraj J (2012): The role of functional single nucleotide polymorphisms of the human glucocorticoid receptor gene NR3C1 in Polish patients with bronchial asthma. Mol Biol Rep 39: 4749‑4757.
31. Panek M, Pietras T, Szemraj J, Kuna P (2014): Association analysis of the glucocorticoid receptor gene (NR3C1) haplotypes (ER22/23EK, N363S, BclI) with mood and anxiety disorders in patients with asthma. Exp Ther Med 8: 662-670.
32. Chomczynski, P., Sacchi, N. 1987. Single - step method of RNA isolation by acid guanidinium thiocyanate- phenol - chloroform extraction. Analytical Biochemistry, 162:156-9.
33. Karbownik MS, Szemraj J, Wieteska Ł, Antczak A, Górski P, Kowalczyk E, Pietras T. Antipsychotic Drugs Differentially Affect mRNA Expression of Genes Encoding the Neuregulin 1-Downstream ErbB4-PI3K Pathway. Pharmacology. 2016;98(1-2):4-12. doi: 10.1159/000444534
34. McCall M, McMurray H, Land Hand, Almudevar A. On non-detects in qPCR data. Bioinformatics. 2014 Aug 15; 30(16): 2310–2316.
35. Christianson C, Goplen N, Zafar I, Irvin C, Good J Jr, Rollins D, Gorentla B, Liu W, Gorska M, Chu H, Martin R, Alam R. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol. 2015;136(1):59-68.
36. Bartemes K, Iijima K, Kobayashi T, Kephart G, McKenzie A, Kita H. IL-33-responsive lineage−CD25+CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs J. Immunol. 2012;188(3):1503-1513.
37. Lee Y, Yap H, Shaari K, Tham C, Sulaiman M, Israf D. Blockade of Eosinophil-Induced Bronchial Epithelial-Mesenchymal Transition with a Geranyl Acetophenone in a Coculture Model. Front Pharmacol. 2017;16; 8:837.
38. Asadi A, Yaghobi Nezhad D, Rafie Javazm A, Khanicheragh P, Mashouri L, Shakeri F, Abbasi M, Afrazian MS, Niknam Z, Abazari O. In Vitro Effects of Curcumin on Transforming Growth Factor-β-mediated Non-Smad Signaling Pathway, Oxidative Stress, and Pro-inflammatory Cytokines Production with Human Vascular Smooth Muscle Cells. Iran J Allergy Asthma Immunol. 2020 Feb 1;19(1):84-93. doi: 10.18502/ijaai.v19i1.2421.
39. Groneberg DA, Witt H, Adcock IM, Hansen G, Springer J. Smads as intracellular mediators of airway inflammation. Exp Lung Res. 2004 Apr-May;30(3):223-50. doi: 10.1080/01902140490276320.
40. Witkowska M, Smolewski P. Białka z rodziny SMAD: współczesna wiedza na temat ich ekspresji i potencjalnej roli w chorobach nowotworowych. Postepy Hig Med Dosw 2014; 68: 301–309.